Colorectal Cancers in Low- and Middle-Income Countries—Demographic Pattern and Clinical Profile of 970 Patients Treated at a Tertiary Care Cancer Center in India | JCO Global Oncology
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
High preoperative CEA and systemic inflammation response index (C-SIRI) predict unfavorable survival of resectable colorectal cancer | World Journal of Surgical Oncology | Full Text
Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer | Scientific Reports
Survival curves of patients with stage III colon cancer according to... | Download Scientific Diagram
Long-term survival of patients with stage III colon cancer treated with VRP- CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio | Journal for ImmunoTherapy of Cancer
Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer - ScienceDirect
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab‐based treatment response in metastatic colorectal cancer - Prager - 2014 - Cancer Science - Wiley Online Library
A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports
Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort | Annals of Surgical Oncology
Frontiers | A Novel Prognostic Model Incorporating Carcinoembryonic Antigen in 3-Week or Longer Postoperative Period for Stage III Colon Cancer: A Multicenter Retrospective Study
CEA levels and circulatory CEA clearance rates in colorectal cancer... | Download Scientific Diagram
Optimal cutoff value of preoperative CEA and CA19-9 for prognostic significance in patients with stage II/III colon cancer | SpringerLink
Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer - Winesh Ramphal, Jeske R.E. Boeding, Maartje van Iwaarden, Jennifer M.J. Schreinemakers, Harm J.T. Rutten, Rogier M.P.H. Crolla,
The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer | BMJ Open
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome | British Journal of Cancer
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Colon Cancer Treatment (PDQ®) - NCI
Colon Cancer: Symptoms, Stages & Treatment
Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy | Anticancer Research
Frontiers | Association of T Stage and Serum CEA Levels in Determining Survival of Rectal Cancer
CEA concentration in supernatant of different colon cancer cell lines | Download Table
